Dr. Dennis Kwiatkowski

Helping Pharma & Biotech Turn Innovation into Impact

📍 Germany🔄 Updated September 2026💼 5 investments📅 5 years investing🗓 Last invested Oct 2025
VC🌍 GermanyInvested this year
5
Total investments
3
Early stage
0
Mid stage
2
Late stage
5y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Oct 2025
Kedi Bioscience consolidates animal and human health to develop advanced therapies for cats.
Private Investor
Aug 2025
Virtonomy introduces v-Patients, enabling medical device developers to perform development and testing in a virtual environment, thereby accelerating development, reducing risks, expenses, and regulatory burden. Our end-to-end digital twin and simulation solution is based on an ever-expanding database of real clinical data to reflect anatomical variability, demographic diversity and pathological conditions.
Private Investor
Jul 2025
Awarded for “most innovative German startup” from German business magazine Bilanz, DiaMonTech has developed a medical device that non-invasively measures your blood glucose without finger pricking, a drop of blood, or a test strip. Simply relax your fingertip on the sensor, wait 5 to 15 seconds, and your blood glucose level will be displayed. Our patented technology works with an invisible infrared light beam that looks into your skin and counts glucose molecules. Diabetes is a global challenge. More than 400 million people worldwide suffer from the disease. Our goal is to make checking your blood glucose level as easy as unlocking your phone. You will be able to get measurements throughout the day without pain or extra costs. Diabetologists suggest that more frequent blood glucose measurements can lead to better overall diabetes management and less diabetes-related illnesses. Until there’s a cure for diabetes, DiaMonTech can make living with it much easier.
Investor
May 2022
Hör auf, nichtssagende Lebensläufe zu vergleichen! Mit Aivy begutachtest du Bewerbende anhand von Stärkenprofilen - erhoben über kurze, mobile Testverfahren. ✓ Bessere Candidate Experience ✓ Kürzere Time-to-Hire ✓ Höhere Trefferquote
Investor
Jan 2021
EpiHeart is a medical device company dedicated to enable surgical administration of novel cellular and gene therapies. Our first focus is in cardiac cellular therapy administered during CABG or LVAD surgery to treat ischemic cardiac scars and heart failure.
early stageMedical Device
Experience · 8 entries
All (8)
Investments (5)
2025
Investor
Oct 2025
Kedi Bioscience consolidates animal and human health to develop advanced therapies for cats.
Managing Partner
Sep 2025
Berlin Sofia Partners is a privately funded family office investing at the intersection of technology, biotech, and digital health.
Private Investor
Aug 2025
Virtonomy introduces v-Patients, enabling medical device developers to perform development and testing in a virtual environment, thereby accelerating development, reducing risks, expenses, and regulatory burden. Our end-to-end digital twin and simulation solution is based on an ever-expanding database of real clinical data to reflect anatomical variability, demographic diversity and pathological conditions.
Private Investor
Jul 2025
Awarded for “most innovative German startup” from German business magazine Bilanz, DiaMonTech has developed a medical device that non-invasively measures your blood glucose without finger pricking, a drop of blood, or a test strip. Simply relax your fingertip on the sensor, wait 5 to 15 seconds, and your blood glucose level will be displayed. Our patented technology works with an invisible infrared light beam that looks into your skin and counts glucose molecules. Diabetes is a global challenge. More than 400 million people worldwide suffer from the disease. Our goal is to make checking your blood glucose level as easy as unlocking your phone. You will be able to get measurements throughout the day without pain or extra costs. Diabetologists suggest that more frequent blood glucose measurements can lead to better overall diabetes management and less diabetes-related illnesses. Until there’s a cure for diabetes, DiaMonTech can make living with it much easier.
2022
Investor
May 2022
Hör auf, nichtssagende Lebensläufe zu vergleichen! Mit Aivy begutachtest du Bewerbende anhand von Stärkenprofilen - erhoben über kurze, mobile Testverfahren. ✓ Bessere Candidate Experience ✓ Kürzere Time-to-Hire ✓ Höhere Trefferquote
Show all 8 entries ↓
Investment activity
2021–2025 · 5 investments
202112022120253
Recent (last 2 years)Earlier